Chinese herbal medicine compound composition capable of relieving acute liver injury and application of Chinese herbal medicine compound composition
The invention discloses a Chinese herbal medicine compound composition capable of relieving acute liver injury and application of the Chinese herbal medicine compound composition. The Chinese herbal medicine compound composition capable of relieving the acute liver injury is obtained through identification, screening and research. The composition is composed of a turmeric extract, a hovenia dulcis thunb extract, an abrus herb extract and a fructus alpiniae oxyphyllae extract. By constructing an acute liver injury animal model, it is proved that the compound composition has good anti-inflammatory and liver-protecting effects and can repair and protect the liver; the liver is protected by effectively relieving inflammatory response in the liver injury process and inhibiting various inflammatory factors, so that the vacuoles in a liver injury model are small, the number of the vacuoles is reduced, and meanwhile, the inflammatory factor infiltration condition is also improved; in addition, STAT3 expression up-regulation in a liver injury model can be promoted, liver cell proliferation after liver injury is promoted, liver repair is promoted, the liver protection effect is achieved, and more effective treatment drugs and treatment means are provided for clinical treatment of liver diseases caused by liver injury..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Europäisches Patentamt - (2024) vom: 02. Feb. Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
LIU WENYI [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-02-02, Last update posted on www.tib.eu: 2024-03-25, Last updated: 2024-03-29 |
---|
Patentnummer: |
CN117482192 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA002676060 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | EPA002676060 | ||
003 | DE-627 | ||
005 | 20240329155902.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240329s2024 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA002676060 | ||
035 | |a (EPA)CN117482192 | ||
035 | |a (EPA)89678911 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a LIU WENYI |e verfasserin |4 aut | |
245 | 1 | 0 | |a Chinese herbal medicine compound composition capable of relieving acute liver injury and application of Chinese herbal medicine compound composition |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2024-02-02, Last update posted on www.tib.eu: 2024-03-25, Last updated: 2024-03-29 | ||
520 | |a The invention discloses a Chinese herbal medicine compound composition capable of relieving acute liver injury and application of the Chinese herbal medicine compound composition. The Chinese herbal medicine compound composition capable of relieving the acute liver injury is obtained through identification, screening and research. The composition is composed of a turmeric extract, a hovenia dulcis thunb extract, an abrus herb extract and a fructus alpiniae oxyphyllae extract. By constructing an acute liver injury animal model, it is proved that the compound composition has good anti-inflammatory and liver-protecting effects and can repair and protect the liver; the liver is protected by effectively relieving inflammatory response in the liver injury process and inhibiting various inflammatory factors, so that the vacuoles in a liver injury model are small, the number of the vacuoles is reduced, and meanwhile, the inflammatory factor infiltration condition is also improved; in addition, STAT3 expression up-regulation in a liver injury model can be promoted, liver cell proliferation after liver injury is promoted, liver repair is promoted, the liver protection effect is achieved, and more effective treatment drugs and treatment means are provided for clinical treatment of liver diseases caused by liver injury. | ||
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a LIN LING |4 aut | |
700 | 0 | |a LIU NIAN |4 aut | |
700 | 0 | |a SU CHILIAN |4 aut | |
700 | 0 | |a LI HAO |4 aut | |
700 | 0 | |a LONG JIANMEI |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 02. Feb. |
773 | 1 | 8 | |g year:2024 |g day:02 |g month:02 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/89678911/publication/CN117482192A1?q=CN117482192 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2024 |b 02 |c 02 |